Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Glucagon
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Recipient : Xeris Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
LifeArc Makes Investment to Support Drug Discovery in Sub-Saharan Africa
Details : The collaboration aims for the development and commercialization of a glucagon product utilizing Xeris’ XeriSol™ technology for use in Beta Bionics’ proprietary bi-hormonal pump and pump systems.
Brand Name : Undisclosed
Molecule Type : Peptide
Upfront Cash : Undisclosed
May 06, 2024
Lead Product(s) : Glucagon
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Recipient : Xeris Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?